The Watchtower's Medical Expert
Thx darkspilver. I,ve tried on a different computer and I get the same dates.
so it looks like they want jws to rely on the advice of the HLC. They could recommend HES starches!!! If jws are in a critical state do they advise re the risks?
Ruby456: I found that a 2012 article does recommend HES starches despite that these are banned in Europe.
Firstly, the 2012 article date is a 'red-herring' - as per above posts - the article is from a 1990 WT publication.
Secondly, Hydroxyethyl Starch HES was NOT banned in Europe in 2012 - it was still available to use all during 2012......
For example in the UK, what Orphan Crow's OP article unfortunately appears to fail to mention is that Hydroxyethyl Starch HES was only withdrawn for use by the UK's public National Health Service (NHS) on 27 June 2013.
darspilver if I wanted to say that HES starches were banned in 2012 I would have said that these were and not these are banned in Europe. But even by 2012 the pendulum had been swinging away from the use of these starches. the article certainly isn't a red herring to me and furthermore the ban only applies to those who are critically ill. the ban was apparently overturned by december 2013 and HES still can be used as a volume expander but for no more than 24 hours and not for people who are contraindicated - like those with kidney problems and sepsis.
And even if the article is from a 1990 publication the date shows that it was still current in 2012 and prolly still current today simply because it carries that date stamp which may be a way of saying when an article was updated and this may be an indication that the info is still current. otherwise I dunno.
Ruby456 - the HES starches have been withdrawn now, but they where not in 2012, only afterwards.
here is the UK's present position on HES starches since 2014
Advice for healthcare professionals:
- HES is only indicated for the treatment of low blood volume due to acute blood loss when crystalloids alone are not considered sufficient.
- Use of HES is contraindicated in:
- kidney impairment or kidney function replacement therapy
- intracranial or cerebral haemorrhage
- critically ill patients (typically admitted to the intensive care unit)
- hyperhydrated patients, including patients with pulmonary oedema
- dehydrated patients
- severe coagulopathy
- severely impaired liver function
- The maximum daily dose of HES is 30 ml per kilogram of bodyweight.
- Only use HES during the first 24 hours of fluid resuscitation treatment.
- Trauma and surgery: carefully weigh the expected benefit of treatment against the uncertainty of the long term safety of treatment. Consider other available treatment options.
- Monitor kidney function in patients receiving HES for at least 90 days. Stop HES treatment at the first sign of kidney injury.
- Stop HES treatment at the first sign of impaired blood clotting.
- Please continue to report suspected adverse drug reactions to HES or any other medicine via the Yellow Card Scheme